Vaccination therapy of patients with metastatic breast and ovarian carcinoma using peptide pulsed dendritic cells.

被引：0
|
作者：
Brossart, P
Stuhler, G
Reichardt, VL
Stefanovic, S
Rammensee, HG
Kurtz, S
Hoffmann, Y
Kanz, L
Brugger, W
机构：
[1] Univ Tubingen, Dept Hematol Oncol & Immunol, D-72074 Tubingen, Germany
[2] Univ Tubingen, Inst Cell Biol, D-72074 Tubingen, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
949
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [31] Long-term Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Pulsed Dendritic Cells
    Kraemer, Markus
    Hauser, Stefan
    Schmidt-Wolf, Ingo G. H.
    ANTICANCER RESEARCH, 2010, 30 (06) : 2081 - 2086
  • [32] Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
    Wierecky, Jan
    Mueller, Martin R.
    Wirths, Stefan
    Halder-Oehler, Edith
    Doerfel, Daniela
    Schmidt, Susanne M.
    Haentschel, Maik
    Brugger, Wolfram
    Schroeder, Stephen
    Horger, Marius S.
    Kanz, Lothar
    Brossart, Peter
    CANCER RESEARCH, 2006, 66 (11) : 5910 - 5918
  • [33] Cellular and humoral immune responses in a patient with metastatic renal cell carcinoma after vaccination with antigen-pulsed dendritic cells
    Höltl, L
    Rieser, C
    Papesh, C
    Ramoner, R
    Bartsch, G
    Thurnher, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 99 - 99
  • [34] Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: A phase 1 study
    Oosterwijk-Wakka, JC
    Tiemessen, DM
    Bleumer, I
    de Vries, IJM
    Jongmans, W
    Adema, GJ
    Debruyne, FMJ
    de Mulder, PH
    Oosterwijk, E
    Mulders, PFA
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (06): : 500 - 508
  • [35] Specific immunotherapy of multiple myeloma patients using idiotype pulsed serum free generated dendritic cells.
    Reichardt, VL
    Milazzo, C
    Brugger, W
    Einsele, H
    Kanz, L
    Brossart, P
    BLOOD, 2001, 98 (11) : 378A - 379A
  • [36] Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells
    Crisci, A
    Su, Z
    Debeck, C
    Dahm, P
    Dannull, J
    Vieweg, J
    JOURNAL OF UROLOGY, 2003, 169 (04): : 142 - 142
  • [37] Specific immunotherapy of multiple myeloma patients using idiotype pulsed serum free generated dendritic cells.
    Reichardt, VL
    Wirths, S
    Milazzo, C
    Brossart, P
    Stuhler, G
    Einsele, H
    Brugger, W
    Kanz, L
    BLOOD, 2000, 96 (11) : 163A - 163A
  • [38] A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.
    Chin, Steve Hsukwo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Extended survival and broad immune responses following vaccination of patients with metastatic melanoma with peptide-pulsed CD34+progenitor derived dendritic cells (DCs).
    Banchereau, J
    Palucka, AK
    Paczesny, S
    Dhodapkar, M
    Johnston, D
    Ueno, H
    Pineiro, L
    Burkeholder, S
    Fay, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 172S - 172S
  • [40] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
    Hsu, FJ
    Benike, C
    Fagnoni, F
    Liles, TM
    Czerwinski, D
    Taidi, B
    Engleman, EG
    Levy, R
    NATURE MEDICINE, 1996, 2 (01) : 52 - 58
12345